Search Results

Filter
  • 1-10 of  80 results for ""Neovascularization, Physiologic drug effects""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects.

  • Authors : Imai A; Angiogenesis Research Laboratory, Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan 48109, USA.; Zeitlin BD

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*drug therapy ; Head and Neck Neoplasms/Head and Neck Neoplasms/Head and Neck Neoplasms/*drug therapy

  • Source: Cancer research [Cancer Res] 2012 Feb 01; Vol. 72 (3), pp. 716-25. Date of Electronic Publication: 2011 Dec 08.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Tumor cells secrete galectin-1 to enhance endothelial cell activity.

  • Authors : Thijssen VL; Department of Radiotherapy, Angiogenesis Laboratory, VU University Medical Center, Amsterdam, the Netherlands.; Barkan B

Subjects: Galectin 1/Galectin 1/Galectin 1/*physiology ; Melanoma, Experimental/Melanoma, Experimental/Melanoma, Experimental/*blood supply ; Teratocarcinoma/Teratocarcinoma/Teratocarcinoma/*blood supply

  • Source: Cancer research [Cancer Res] 2010 Aug 01; Vol. 70 (15), pp. 6216-24. Date of Electronic Publication: 2010 Jul 20.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.

  • Authors : Cho SG; Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology and Department of Molecular and Cellular Medicine, Texas A&M University Health Science Center, Houston, Texas 77030, USA.; Yi Z

Subjects: Endothelial Cells/Endothelial Cells/Endothelial Cells/*drug effects ; Neovascularization, Pathologic/Neovascularization, Pathologic/Neovascularization, Pathologic/*drug therapy ; Neovascularization, Physiologic/Neovascularization, Physiologic/Neovascularization, Physiologic/*drug effects

  • Source: Cancer research [Cancer Res] 2009 Sep 01; Vol. 69 (17), pp. 7062-70. Date of Electronic Publication: 2009 Aug 11.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

  • Authors : Pang X; Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.; Yi Z

Subjects: Neovascularization, Pathologic/Neovascularization, Pathologic/Neovascularization, Pathologic/*prevention & control ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*prevention & control ; Triterpenes/Triterpenes/Triterpenes/*pharmacology

  • Source: Cancer research [Cancer Res] 2009 Jul 15; Vol. 69 (14), pp. 5893-900. Date of Electronic Publication: 2009 Jun 30.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation.

  • Authors : Lamy S; Laboratoire de Médecine Moléculaire, Hôpital Ste-Justine-Université du Québec à Montréal, Québec, Canada.; Bédard V

Subjects: Apigenin/Apigenin/Apigenin/*pharmacology ; Cell Movement/Cell Movement/Cell Movement/*drug effects ; Luteolin/Luteolin/Luteolin/*pharmacology

  • Source: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2008 Nov; Vol. 1 (6), pp. 452-9.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model:

Record details

×
Academic Journal

Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity.

  • Authors : Pyun BJ; Department of Biochemistry, College of Sciences, Yonsei University, Seoul, 120-749, South Korea.; Choi S

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Capsaicin/Capsaicin/Capsaicin/*analogs & derivatives ; Neovascularization, Physiologic/Neovascularization, Physiologic/Neovascularization, Physiologic/*drug effects

  • Source: Cancer research [Cancer Res] 2008 Jan 01; Vol. 68 (1), pp. 227-35.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.

  • Authors : Tran TC; Zygogen, LLC, 24 Peachtree Center Avenue, 520 Kell Hall, Atlanta, GA 30303, USA.; Sneed B

Subjects: Automation* ; Drug Evaluation, Preclinical*; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology

  • Source: Cancer research [Cancer Res] 2007 Dec 01; Vol. 67 (23), pp. 11386-92.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

  • Authors : Rogers MS; Vascular Biology Program and Department of Ophthalmology, Children's Hospital, and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA. ; Christensen KA

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Antigens, Bacterial/Antigens, Bacterial/Antigens, Bacterial/*pharmacology ; Bacterial Toxins/Bacterial Toxins/Bacterial Toxins/*pharmacology

  • Source: Cancer research [Cancer Res] 2007 Oct 15; Vol. 67 (20), pp. 9980-5.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.

  • Authors : Chi SL; Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.; Wahl ML

Subjects: Angiostatins/Angiostatins/Angiostatins/*metabolism ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*immunology ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacology

  • Source: Cancer research [Cancer Res] 2007 May 15; Vol. 67 (10), pp. 4716-24.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF.

Subjects: Hydroxyeicosatetraenoic Acids/Hydroxyeicosatetraenoic Acids/Hydroxyeicosatetraenoic Acids/*pharmacology ; Neovascularization, Physiologic/Neovascularization, Physiologic/Neovascularization, Physiologic/*drug effects ; STAT3 Transcription Factor/STAT3 Transcription Factor/STAT3 Transcription Factor/*metabolism

  • Source: Cancer research [Cancer Res] 2007 May 01; Vol. 67 (9), pp. 4328-36.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
  • 1-10 of  80 results for ""Neovascularization, Physiologic drug effects""